title: Variceal bleeding and long-acting octreotide: a new addition to the armamentarium?
authors.forename: George A
authors.initials: GA
authors.lastname: Sanchez
authors.forename: Nisa
authors.initials: N
authors.lastname: Kubiliun
authors.forename: Jamie S
authors.initials: JS
authors.lastname: Barkin
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000369:Aged, 80 and over; D004359:Drug Therapy, Combination; D004932:Esophageal and Gastric Varices / Q000209:etiology* / Q000517:prevention & control*; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006470:Hemorrhage / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans; D006975:Hypertension, Portal / Q000188:drug therapy; D008103:Liver Cirrhosis / Q000150:complications*; D015282:Octreotide / Q000627:therapeutic use*
chemical_list: D000319:Adrenergic beta-Antagonists; D005765:Gastrointestinal Agents; D015282:Octreotide